stroke in the era of noacs george ntaios md, msc (stroke medicine), phd university of thessaly,...
TRANSCRIPT
Stroke in the era of NOACs
George Ntaios MD, MSc (Stroke Medicine), PhD
University of Thessaly, Greece
Oslo11/12/2015
Disclosures
Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.Honoraria: Medtronic; Quintiles; Boehringer-Ingelheim.Speaker fees: Sanofi; Boehringer-Ingelheim; Galenica; Elpen; BayerSupport to attend conferences: Bayer; Sanofi-Aventis; Pfizer; Lundbeck; Boehringer-Ingelheim; Galenica; Elpen; BMS Participation in trials:
– NAVIGATE-ESUS / National Coordinator (Greece)– GLORIA-AF / Sub-investigator (Larissa).– FOURIER / Principal investigator (Larissa).– PRECIOUS / National Coordinator (Greece).– ENOS / National Coordinator (Greece).– EBBINGHAUS / Principal Investigator (Larissa).– BIOSIGNAL / Principal Investigator (Larissa).– PREVISE / Principal investigator (Larissa).
Hercules and Lernaean Hydraby Lorenzo Matialli, Habsburg Palace, Vienna
Anticoagulation after AF-stroke: how soon (or late?)
Anticoagulation after AF-stroke: how soon (or late?)
Anticoagulation after AF-stroke: how soon (or late?)
Reasons to start early
• Low NIHSS • Small/no brain infarction on MRI• High recurrence risk e.g. thrombus on
echo• No haemorrhagic transformation• Patient is clinically stable• Young patient• Blood pressure is controlled
Reasons to wait
• High NIHSS • Large/moderate brain infarction• Haemorrhagic transformation• Neurologically unstable• Elderly patient• Uncontrolled hypertension
The 1-3-6-12 rule
TIA 1 day
Small infarct 3 days
Moderate infarct 6 days
Large infarct 12 days
NOACs could be the answer?
Ntaios et al. Stroke 2012
Intracranial haemorrhage while on anticoagulants
ESO ICH Guidelines
Steiner et al. Int J Stroke. 2014
Ntaios et al. Int J Stroke. 2015;Suppl A100:128-35
ESO ICH Guidelines
Steiner et al. Int J Stroke. 2014
NOACs could be the answer?
Ntaios et al. Stroke 2012
Ntaios & Lip. Curr Opin Neurol 2015
Our patient (… and his grand-grand-son)
81yrs
Fully independent at 3months
Hypertensive, Non-smoker, non-diabetic
LDL: 104mg/dl
LA diameter: 42mm
Triplex: -
24hrs ECG: -
Hart et al. Lancet Neurol 2014; 13: 429–38
ESUS: Embolic Strokes of Undetermined Source
ESUS: diagnostic criteria
Stroke detected by CT or MRI that is not lacunar.
Absence of extracranial or intracranial atherosclerosis causing >50% luminal stenosis in arteries supplying the area of ischemia.
No major-risk cardioembolic source of embolism (permanent or paroxysmal AF, sustained atrial flutter, intracardiac thrombus, prosthetic cardiac valve, atrial myxoma or other cardiac tumours, mitral stenosis, recent (<4 weeks) MI, LVEF<30%, valvular vegetations, or infective endocarditis).
No other specific cause of stroke identified.
Hart et al. Lancet Neurol 2014; 13: 429–38
ESUS: potential causes
Hart et al. Lancet Neurol 2014; 13: 429–38
Hart et al. Lancet Neurol 2014; 13: 429–38
ESUS: Embolic Strokes of Undetermined Source
ESUS in the Athens Stroke Registry
Ntaios et al. Stroke 2015; 46:176-81
ESUS: stroke severity
Ntaios et al. Stroke 2015; 46:176-81
ESUS: 5-yrs functional outcome
Ntaios et al. Stroke 2015; 46:2087-93
ESUS: 5-yrs stroke recurrence
Ntaios et al. Stroke 2015; 46:2087-93
So, how to treat my ESUS patient?
Furie et al. Stroke 2011;42:227-76
Approach 1
So, how to treat my ESUS patient?
Approach 2
So, how to treat my ESUS patient?
Approach 3
RESPECT - ESUS
Dabigatran 110/150 1x2
Aspirin 100mg 1x1R
NAVIGATE - ESUS
Rivaroxaban 15mg 1x1
Aspirin 100mg 1x1R
ATTICUS
Apixaban
Aspirin 100mg 1x1R
- Everybody gets happy!
- Almost half stroke patients get an anticoagulant!
Stroke is a syndrome, not a disease.
Neither a “general” neurologist nor a “general” physician is truly qualified to care for all aspects of stroke, without special training.
We are attracted to the concept of “strokology” as a discipline with specific accreditation.
NOACs, stroke & the future
UNTREATED ON WARFARIN
ON A NOAC
2 3
INRLow Normal High
IS HS ISISHSHS
Courtesy of Dr. Pinachyan
Take-home messages
NOACs are here to stay, to raise new questions & provide answers to unmet needs.
ESUS: potetial new indication for NOACs.
Stroke Medicine is rapidly changing (…and so should we)!